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Introduction: Modafinil is a wake-promoting agent approved by FDA for the 
treatment of narcolepsy and shift work sleep disorder. Due to its insolubility in 
water, the drug exhibits low oral bioavailability. Studies have shown that 
formulating poorly-soluble drugs as nanoparticles can improve the drugs 
physicochemical properties. Electrospraying is an uncomplicated and cost-benefit 
method for preparing nanoparticles that can easily be scaled up. 
Methods and Results: Modafinil and Eudragit RS100 were co-dissolved in 
methanol and acetone (1:1) with the drug: polymer ratios of 1:5 and 1:10 at various 
total solution concentrations (10%, 15% and 20%). The solutions were injected 
through a capillary tube on a Teflon screen at a rate of 2 ml/h. A voltage of 20-25 kV 
was applied between the injection needle and the Teflon screen. The particle size 
and morphology of resultant nanoparticles and nanofibers were evaluated via 
scanning electron microspore (SEM). Thermal behavior and crystallinity of the 
samples were studied by differential scanning calorimeter (DSC) and Powder X-ray 
diffraction (PXRD). Fourier transform infrared spectroscopy (FTIR) was used to 
determine any possible interaction between the drug and the polymer. In vitro drug 
release profile was studied at a pH of 6.8 via USP apparatus II. 
SEM results suggested that solutions with lower concentration created nanoparticles 
(100-300 nm) while increasing the concentration resulted in formation of nanofibers 
(50-100 nm). DSC and PXRD analysis revealed that electrosprayed Modafinil was 
transferred from crystalline to amorphous state. FTIR results indicated that hydrogen 
bonds might have formed between the drug and polymer. Drug release profile 
revealed that electrospraying process modified drug release pattern. Some of the 
formulations managed to increase the release rate whereas other formulations 
resulted in slower release. 
Conclusions: Electrospraying is a suitable method for fabricating nanofibers and 
nanoparticles of Modafinil. The resultant nanoformulations show properties such as 
reduced size, decreased crystallinity and modified release rate, thus help Modafinil 
to have higher oral bioavailability.  
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